Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitro.
Zhang Y., Wang Y., Wang L., Zhang Y., Qin Y., Chen T.
Laboratory Study on Immune Modulation, published in Life Sci (2012) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Life Sci (2012)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 23123441
- DOI
- 10.1016/j.lfs.2012.10.015
- Citations
- 11
Abstract (original English)
Aims Adipose-derived mesenchymal stem cells (ADMSCs) are considered as a good cell source for regenerative medicine with their self-renew capacity, multilineage differentiation and immunomodulatory potency. Based on this background, the aim of this study was to evaluate the influence of Rehmannia glutinosa oligosaccharide (RGO), a traditional Chinese medicine, on human ADMSCs' proliferation, H(2)O(2)-induced apoptosis, and secretion of Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in vitro. Main methods Human ADMSCs were isolated and cultured in vitro. Then flow cytometry was carried out to characterize the cells, and MTT assay was performed to detect the proliferation. H(2)O(2)-induced apoptosis was evaluated by flow cytometry. VEGF and HGF production were detected by ELISA kits. Key findings Human ADMSCs were positive for CD90 and CD29, but negative for CD31, CD34 and CD45. The results also indicate that RGO can promote the proliferation and alleviate H(2)O(2)-induced apoptosis of human ADMSCs. The mechanism of RGO's protective effect may involve the up-regulation of VEGF and HGF. Significance The present study indicates that RGO may increase the viability and proliferative capacity and alleviate H(2)O(2)-induced apoptosis of human ADMSCs via the paracrine release of VEGF and HGF. These results indicate that RGO application will enhance stem cel
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol